Table 4.
Outcomes | Non-COVID-19 (n = 12) | COVID-19 (n = 33) | p |
---|---|---|---|
Comorbidities | |||
● Diabetes ● Systemic Hypertension ● COPD ● Heart Failure ● Ischemic Heart Disease |
1 (8.3) 6 (50) 0 1 (8.3) 0 |
11 (33.3) 18 (54.5) 1 (3) 3 (9.1) 5 (15.2) |
0.09 0.78 0.54 0.93 0.15 |
Mechanical ventilation a | 9 (75) | 33 (100) | < 0.01 |
Renal replacement therapy a | 1 (8.3) | 13 (39.3) | 0.04 |
RV failure a | 2 (16.7) | 2 (6.1) | 0.26 |
Duration of mechanical ventilation b | 1 (43.7) | 22 (52) | < 0.01 |
Days in Critical Care Unit b | 1 (28.1) | 28 (47.9) | < 0.01 |
In-Hospital stay b | 6 (31.8) | 29 (46) | < 0.01 |
Data presented as: a total of patients (%), b mean (standard deviation). Abbreviations: RV: right ventricular. Statistical analysis: U Mann-Whitney test was performed for numeric variables, and Chi square test was used for nominal/ordinal variables